Answers are grounded in this paper and cite their sources.
This review summarizes key findings from the ATLAS-TIMI 51, TRACER, and PALLAS trials regarding anti-thrombotic therapy in ACS and dronedarone in permanent AF.
Several key reports from the American Heart Association meeting, held in Orlando (FL, USA) in November 2011, are presented related to anti-thrombotic therapy in acute coronary syndrome and the use of dronedarone in permanent atrial fibrillation is discussed in this brief (and selective) overview of this meeting. A summary of the ATLAS-TIMI-51, TRACER and PALLAS trials is provided.
No takes yet. Share an insight, caveat, or question.
Shantsila et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: